01 10Bayer Inc.
02 7CSL Behring Canada Inc.
01 102210038
02 72514646
01 10ANTIHEMOPHILIC FACTOR (RECOMBINANT)
02 7ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT)
01 15POWDER FOR SOLUTION
02 1POWDER FOR SUSPENSION
03 1Blank
01 102017-07-09
02 72023-10-27
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH VIAL ADAPTER)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 250 IU
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH VIAL ADAPTER)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 500 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH VIAL ADAPTER)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 1000 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH VIAL ADAPTER)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 2000 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH VIAL ADAPTER)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 3000 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH BIO-SET)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 250 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH BIO-SET)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 500 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH BIO-SET)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 1000 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH BIO-SET)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 2000 IU
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
Antihemophilic factor recombinant
Brand Name : KOVALTRY (SUPPLIED WITH BIO-SET)
Patent Number : 2210038
Filing Date : 1997-07-09
Strength per Unit : 3000 IU
Dosage Form :
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2017-07-09
Date Granted : 2007-03-13
